Literature DB >> 22851984

Quantifying limitations in chemotherapy data in administrative health databases: implications for measuring the quality of colorectal cancer care.

Robin Urquhart1, Daniel Rayson, Geoffrey A Porter, Eva Grunfeld.   

Abstract

Reliable chemotherapy data are critical to evaluate the quality of care for patients with colorectal cancer who are treated with curative intent. In Canada, limitations in the availability and completeness of chemotherapy data exist in many administrative health databases. In this paper, we discuss these limitations and present findings from a chart review in Nova Scotia that quantifies the completeness of chemotherapy capture in existing databases. The results demonstrate that even basic information on cancer treatment in administrative databases can be insufficient to perform the types of analyses that most decision-makers require for quality-of-care measurement.

Entities:  

Year:  2011        PMID: 22851984      PMCID: PMC3167566     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  14 in total

Review 1.  NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer.

Authors: 
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

2.  Accuracy of administrative claims data for polypectomy.

Authors:  Jonathan M Wyse; Lawrence Joseph; Alan N Barkun; Maida J Sewitch
Journal:  CMAJ       Date:  2011-06-13       Impact factor: 8.262

3.  Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.

Authors:  Marcy Winget; Shakhawat Hossain; Yutaka Yasui; Andrew Scarfe
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

4.  Chart documentation quality and its relationship to the validity of administrative data discharge records.

Authors:  Lawrence So; Cynthia A Beck; Susan Brien; James Kennedy; Thomas E Feasby; William A Ghali
Journal:  Health Informatics J       Date:  2010-06       Impact factor: 2.681

5.  Determining the quality of breast cancer care: do tumor registries measure up?

Authors:  N A Bickell; M R Chassin
Journal:  Ann Intern Med       Date:  2000-05-02       Impact factor: 25.391

6.  Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study.

Authors:  G Gatta; R Capocaccia; M Sant; C M Bell; J W Coebergh; R A Damhuis; J Faivre; C Martinez-Garcia; J Pawlega; M Ponz de Leon; D Pottier; N Raverdy; E M Williams; F Berrino
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

7.  Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.

Authors:  D J Jonker; K Spithoff; J Maroun
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-03-11       Impact factor: 4.126

8.  Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.

Authors:  Franco Berrino; Roberta De Angelis; Milena Sant; Stefano Rosso; Magdalena Bielska-Lasota; Magdalena B Lasota; Jan W Coebergh; Mariano Santaquilani
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

9.  Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.

Authors:  A Figueredo; S Fine; J Maroun; C Walker-Dilks; S Wong
Journal:  Cancer Prev Control       Date:  1997-10

10.  Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.

Authors:  Winson Y Cheung; Bridget A Neville; Craig C Earle
Journal:  Dis Colon Rectum       Date:  2009-06       Impact factor: 4.585

View more
  3 in total

1.  Inequity in access to guideline-recommended colorectal cancer treatment in Nova Scotia, Canada.

Authors:  André R Maddison; Yukiko Asada; Robin Urquhart; Grace Johnston; Frederick Burge; Geoff Porter
Journal:  Healthc Policy       Date:  2012-11

2.  Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis.

Authors:  Daniel Rayson; Robin Urquhart; Martha Cox; Eva Grunfeld; Geoff Porter
Journal:  J Oncol Pract       Date:  2012-07       Impact factor: 3.840

3.  Timely access and quality of care in colorectal cancer: a population-based cohort study using administrative data.

Authors:  Geoffrey Porter; Robin Urquhart; Cynthia Kendell; Jingyu Bu; Yarrow McConnell; Eva Grunfeld
Journal:  BMC Res Notes       Date:  2013-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.